This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: University of California, Cedars-Sinai Medical Center. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2020
Title: Min Song: Innovator in Cancer Assessment Technologies
Introduction
Min Song is a prominent inventor based in Los Angeles, CA. He has made significant contributions to the field of cancer assessment through his innovative methods and systems. With a total of 2 patents, his work focuses on improving the diagnosis and treatment of cancer.
Latest Patents
Min Song's latest patents include a method for assessing the disease condition of cancer. This method involves receiving a blood sample from a subject, isolating circulating tumor cells (CTCs), measuring their sizes, and comparing the size distribution to a reference. This process allows for a more accurate assessment of the cancer condition. Another notable patent is a system for isolating preselected cell types from a fluid sample. This system utilizes a cell-capture fluidic chip designed to maintain a fluid-tight seal during operation, ensuring effective isolation of specific cell types for further analysis.
Career Highlights
Throughout his career, Min Song has worked with esteemed institutions such as the University of California and Cedars-Sinai Medical Center. His experience in these organizations has allowed him to develop and refine his innovative technologies in cancer assessment.
Collaborations
Min Song has collaborated with notable professionals in his field, including Hsian-Rong Tseng and Jiaoti Huang. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Min Song's contributions to cancer assessment technologies highlight his dedication to improving healthcare outcomes. His innovative patents and collaborations with leading professionals underscore his impact in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile